Follow the money

FDA Authorizes Merck's COVID-19 Pill Weeks After US Makes $2.2 Billion Purchase

 

The U.S. federal government previously agreed to purchase 3.1 million courses of the Merck antiviral drug for about $2.2 billion.

  $709.67 per unit

 

As for Pfizer’s drug, Paxlovid, the United States purchased 10 million courses several weeks ago in a deal worth more than $5 billion : On sale at only $500.00 per unit.

 

https://www.theepochtimes.com/mkt_morningbrief/fda-authorizes-mercks-at-home-covid-19-pill_4174645.html?utm_source=Morningbrief&utm_medium=email&utm_campaign=mb-2021-12-24&mktids=e2885dee5a222f426922dc5edc1c3bf4&est=epL7F%2F8zXvrR27YUfppdS%2Beh3ApAMPNRBckndJ0w9NLv%2BFF75CGBRfjXOseB9Us%3D

 

Then there’s the cost. Although we don’t yet know molnupiravir’s price tag, the federal government has committed to buying 700 million doses for $1.2 billion. That’s 40 times the cost of producing the drug—a major expense by our deeply indebted government when we have a cost-effective option available now. It costs six cents to manufacture one ivermectin pill, and a full treatment course can be purchased for less than a dollar in many countries.

https://www.realclearmarkets.com/articles/2021/10/15/why_does_the_fda_hype_mercks_covid_drug_but_dismiss_ivermectin_799071.html

 

    40 times the cost of manufacturing? Guess the real cost is buy all those politicians.